BRICANYL 5 mg/2 ml, solution for inhalation by nebulizer in a single-dose container 20 single-dose containers of 2 ml
Active ingredients: Terbutaline sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation20 single-dose containers of 2 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRICANYL 5 mg/2 mL, solution pour inhalation par nébuliseur en récipient unidose
- Pharmaceutical form
- solution pour inhalation
- Route of administration
- inhalée
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène suremballée(s)/surpochée(s) de 2 ml
- Marketing authorisation holder
- ASTRAZENECA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 May 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68242177CIP73657321CIP133400936573215Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE TERBUTALINEsolution | 5,0 mg · un flacon de 2 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.